Applied DNA Sciences (APDN) Misses Q1 EPS by 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.63), $0.36 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.02 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Eversource Energy (ES) Tops Q3 EPS by 18c; offers guidance
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
